Who Owns Lexaria Bioscience Stock?
NASDAQ: LEXXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 2:37 PM ET
Ownership breakdown
- Held by institutions
- 6.62%
- Held by insiders
- 3.32%
- Institutional holders
- 29
- Institutions 6.6%
- Insiders 3.3%
- Public and other 90.1%
Who owns Lexaria Bioscience stock?
Institutional investors own about 6.6% of Lexaria Bioscience's shares, spread across 29 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 3.32% of LEXX.
The largest institutional holders are Invenomic Capital Management, LP (1.09%), Vanguard Capital Management LLC (0.94%) and Geode Capital Management, LLC (0.79%). Together, the top 10 institutions control 4.6% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their LEXX positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LEXX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Invenomic Capital Management, LP | 23.05K | 1.09% | -21.8% |
| Vanguard Capital Management LLC | 19.90K | 0.94% | +34.3% |
| Geode Capital Management, LLC | 16.69K | 0.79% | -14.9% |
| Citadel Advisors Llc | 10.46K | 0.50% | +1061.3% |
| Toronto Dominion Bank | 6.67K | 0.32% | -28.6% |
| Vanguard Fiduciary Trust Co | 6.28K | 0.30% | 0.0% |
| HRT Financial LP | 4.34K | 0.21% | +252.3% |
| UBS Group AG | 3.13K | 0.15% | -10.9% |
| Northern Trust Corporation | 2.65K | 0.13% | +116.6% |
| State Street Corporation | 2.62K | 0.12% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LEXX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 19.90K | 0.94% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 8.69K | 0.41% |
| NORTHERN LIGHTS FUND TRUST II-Invenomic Fund | 6.67K | 0.32% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 2.13K | 0.10% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 1.74K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 592 | 0.03% |
Frequently asked questions
Who is the largest shareholder of Lexaria Bioscience?
Invenomic Capital Management, LP is the largest institutional shareholder of LEXX, owning 1.09% of shares outstanding (23.05K shares) as of its latest 13F filing.
What percentage of Lexaria Bioscience is owned by institutions?
Institutions own about 6.6% of LEXX shares and 6.8% of the public float.
How much of Lexaria Bioscience do insiders own?
Insiders, such as officers and directors, own about 3.32% of LEXX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.